Can cocoa lower your heart disease risk?

In a recent study published in Nutrients, researchers reviewed the effects of cocoa consumption on anthropometric measurements, blood pressure, and glycemic and lipid profiles to elucidate its impact on the risk of cardiovascular disease (CVD).

Study: Effects of Cocoa Consumption on Cardiometabolic Risk Markers: Meta-Analysis of Randomized Controlled Trials. Image Credit: iprachenko /

CVDs and the need for dietary interventions

Current estimates indicate that CVDs claim over 17.9 million lives each year, thus making these diseases the leading global cause of human mortality. In Brazil, over 397,000 individuals died due to CVDs in 2019, 43% of whom succumbed to coronary artery diseases.

The Framingham Heart Study is considered the pioneer of cardiometabolic research, as a significant portion of current cardiometabolic risk stratification has been based on its concepts. This study stratifies CVD risk based on age, sex, systolic and diastolic blood pressure, cholesterol, body mass index (BMI), and behaviors, including smoking and alcohol dependence. Notably, many of these factors have shown strong associations with diet, with a growing body of literature highlighting the role of healthy diets, such as the Mediterranean diet, in reducing CVD risk.

Cocoa is a fruit that is rich in polyphenols, the majority of which are flavonoids that have been shown to reduce the risk of both CVDs and artherosclerosis by reducing inflammation, improving endothelial function, and lowering blood pressure. More specifically, cocoa appears to activate nitric oxide (NO) and neutralize free radicals, thereby reducing oxidative stress and protecting cells from damage.  

To date, previous studies aimed at revealing the potential benefits of cocoa consumption on the Framingham risk score, a measure of cardiometabolic risk, have produced mixed results.

About the study

The present study involved a systematic review and meta-analysis of randomized control trials (RCTs) evaluating the associations between cocoa consumption and cardiometabolic risk markers.

RCTs that included individuals 18 years of age and older that used cocoa, its extracts, or dark chocolate, with a cocoa content of 70% or higher, were eligible for review inclusion. Studies conducted on pregnant or post-menopausal women, animal models, and those investigating the association between cardiometabolic risk and other comorbidities like cancer were excluded from the study.

Relevant publications were identified using six electronic scientific databases including MEDLINE, Web of Science, EMBASE, SciELO, LILACS, and Cochrane. The Rayyan reference manager was used for study data extraction and management.

Data on the reviewer, author, journal, publication year, country, methodology, cohort size, and participant details, including age, sex, amount of cocoa supplementation, follow-up period, and reported outcomes, were collected. The Cochrane risk of bias (RoB) tool was used to calculate bias risk between included studies.

The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool was used to determine the strength of evidence of each included study against other studies in a paired-effects fashion. Higgins (I2) was used to test the degree of heterogeneity of included publications.

Study findings

Of the 3,807 studies initially identified in the database search, 31 met the study inclusion criteria and were included in the meta-analysis. Taken together, these studies included a cohort size of 1,110 cases and 876 controls.

Thirteen studies assessed the effects of cocoa supplementation on healthy participants, three on participants with metabolic syndrome, two on hypertension or pre-hypertension, seven with T2D, one on insulin resistance, and four on dyslipidemia or excess weight.

Cocoa consumption had no statistically significant effects on total body mass, waist circumference, or BMI. While abdominal circumference was reduced following cocoa supplementation interventions, these findings were borderline and were associated with high heterogeneity.

However, cocoa polyphenol consumption was found to reduce adverse lipid profiles, fasting blood glucose levels, and blood pressure, with the degree of reductions positively correlated with the dosage of cocoa intake. These findings may explain previously contrasting reports between studies, as cocoa elicited cardioprotective effects despite showing no improvements in some historic CVD risk markers.

Taken together, cocoa consumption, including cocoa supplements and dark chocolate, appears to impart protective effects on cardiometabolic risk markers and have a clinically significant impact on CVD risk reduction.

We suggest that the consumption of polyphenol-rich cocoa could be part of a strategy aimed at promoting cardiovascular health.”

Journal reference:
  • Arisi, T. O. P., da Silva, D. S., Stein, E., et al. (2024). Effects of Cocoa Consumption on Cardiometabolic Risk Markers: Meta-Analysis of Randomized Controlled Trials. Nutrients 16(12):1919. doi:10.3390/nu16121919
Hugo Francisco de Souza

Written by

Hugo Francisco de Souza

Hugo Francisco de Souza is a scientific writer based in Bangalore, Karnataka, India. His academic passions lie in biogeography, evolutionary biology, and herpetology. He is currently pursuing his Ph.D. from the Centre for Ecological Sciences, Indian Institute of Science, where he studies the origins, dispersal, and speciation of wetland-associated snakes. Hugo has received, amongst others, the DST-INSPIRE fellowship for his doctoral research and the Gold Medal from Pondicherry University for academic excellence during his Masters. His research has been published in high-impact peer-reviewed journals, including PLOS Neglected Tropical Diseases and Systematic Biology. When not working or writing, Hugo can be found consuming copious amounts of anime and manga, composing and making music with his bass guitar, shredding trails on his MTB, playing video games (he prefers the term ‘gaming’), or tinkering with all things tech.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Francisco de Souza, Hugo. (2024, June 21). Can cocoa lower your heart disease risk?. News-Medical. Retrieved on July 22, 2024 from

  • MLA

    Francisco de Souza, Hugo. "Can cocoa lower your heart disease risk?". News-Medical. 22 July 2024. <>.

  • Chicago

    Francisco de Souza, Hugo. "Can cocoa lower your heart disease risk?". News-Medical. (accessed July 22, 2024).

  • Harvard

    Francisco de Souza, Hugo. 2024. Can cocoa lower your heart disease risk?. News-Medical, viewed 22 July 2024,


  1. Chidambaram Sriswamy Chidambaram Sriswamy India says:

    Well reviewd

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Early adult weight gain linked to poor heart health in later life, study finds